Jincheng Wu

4PUBLICATIONS
56CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 22, 2026
Targeting CRTC2 reverses STK11 mutant NSCLC tumor resistance to immunotherapy.

|Mar 21, 2025
The Impact of the Tumor Microenvironment on the Effect of IL-1β Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.

Benjamin J Solomon, Daniel S W Tan, Gilberto de Castro

|Apr 11, 2023
Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses.

Rohan Diwanji, Neil A O'Brien, Jiyoung E Choi

Pageof 1